MHTX — Manhattan Scientifics Cashflow Statement
0.000.00%
Last trade - 00:00- $0.56m
- $1.63m
Annual cashflow statement for Manhattan Scientifics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.22 | 4.31 | -3.64 | -2.73 | -1.17 |
| Depreciation | |||||
| Non-Cash Items | 0.564 | -4.96 | 3.05 | 2.05 | 0.462 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.34 | 0.26 | 0.168 | 0.328 | 0.512 |
| Change in Prepaid Expenses | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.316 | -0.388 | -0.421 | -0.349 | -0.19 |
| Capital Expenditures | — | -0.004 | 0 | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.34 | 0.484 | 0.3 | 0.332 | 0.102 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Cash from Investing Activities | 0.34 | 0.48 | 0.3 | 0.332 | 0.102 |
| Financing Cash Flow Items | — | — | 0 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.15 | 0 | 0 | -0.04 | -0.02 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.174 | 0.092 | -0.121 | -0.057 | -0.108 |